News
Earlier this summer the FDA asked Moderna for more efficacy data on its flu vaccine before it could review an mRNA-based ...
In a July 9 memo, the director of the FDA's Center for Biologics Evaluation and Research contended there was not enough ...
MADRID and CAMBRIDGE, Mass., July 21, 2025 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733015, Ticker: ORY), a clinical-stage biopharmaceutical company and a European leader in ...
NanoViricides, Inc. (NYSE American: NNVC) , a clinical-stage innovator in broad-spectrum antivirals, announced near-finalization of its adaptive clin ...
AI in Drug Discovery Market to Surge to US$ 9.07 Billion by 2030, Registering a Strong CAGR of 29.1%
The global AI in drug discovery market size was US$ 910.7 million in 2021. The global AI in drug discovery market size is forecast to reach US$ 9,072.2 million by 2030, growing at a compound annual ...
AI also supports reverse vaccinology, where pathogen genomes are computationally analyzed to identify immunogenic regions ...
NanoViricides, Inc. (NYSE American: NNVC) , a clinical-stage pioneer in host-mimetic nanomedicine, affirmed its preparedness to address the continued ...
Seongnam, South Korea Saturday, July 19, 2025, 12:00 Hrs [IST] ...
Public hospitals have negotiated with pharmaceutical companies as part of efforts to bring down operational costs and ...
Does colchicine work for CVD or doesn’t it? That’s the question the study authors hoped to answer, but there’s little ...
Market OverviewThe global Cancer Immunotherapy Market is valued at USD 121.4 Billion in 2024 and is projected to reach a ...
Market OverviewThe global Epilepsy Drugs Market is valued at USD 10.63 billion in 2024 and is projected to reach a value ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results